OTEZLA 20 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC-Aluminium de 56 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930305744
  • CIP7 3030574
  • CIS 66078074
  • Registration number EU/1/14/981

What the source publishes

Holder
AMGEN EUROPE
Active ingredients
APRÉMILAST
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) PVC-Aluminium de 56 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription réservée aux spécialistes et services PEDIATRIE ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services RHUMATOLOGIE ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I
Marketing status
Déclaration de commercialisation
Authorised on
2024-10-21
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930305744
{
  "cis": "66078074",
  "cip7": "3030574",
  "form": "comprimé pelliculé",
  "name": "OTEZLA 20 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC-Aluminium de 56 comprimé(s)",
  "cip13": "3400930305744",
  "holder": "AMGEN EUROPE",
  "routes": [
    "orale"
  ],
  "holders": [
    "AMGEN EUROPE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "379.85",
  "authorisedOn": "2024-10-21",
  "compositions": [
    {
      "name": "APRÉMILAST",
      "nature": "SA",
      "strength": "20 mg",
      "linkageNumber": "1",
      "substanceCode": "41238",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription réservée aux spécialistes et services PEDIATRIE ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services RHUMATOLOGIE ; prescription réservée aux spécialistes et services DERMATOLOGIE ; liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "378.83",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "OTEZLA 20 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) thermoformée(s) PVC-Aluminium de 56 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30%"
  ],
  "marketingDeclaredOn": "2025-06-11",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "APRÉMILAST"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription réservée aux spécialistes et services PEDIATRIE",
    "prescription réservée aux spécialistes et services MEDECINE INTERNE",
    "prescription réservée aux spécialistes et services RHUMATOLOGIE",
    "prescription réservée aux spécialistes et services DERMATOLOGIE",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/14/981",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930305744"